M
Meenakshi Balganesh
Researcher at AstraZeneca
Publications - 13
Citations - 583
Meenakshi Balganesh is an academic researcher from AstraZeneca. The author has contributed to research in topics: Efflux & Mycobacterium tuberculosis. The author has an hindex of 9, co-authored 13 publications receiving 535 citations.
Papers
More filters
Journal ArticleDOI
Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosis.
TL;DR: The study indicates that the efflux pump knockout strains are more susceptible to PSI than the wild type, strongly suggesting an important role for efflux pumps in the intrinsic resistance of M. tuberculosis toPSI.
Journal ArticleDOI
Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis
Shahul Hameed P,Suresh Solapure,Kakoli Mukherjee,Vrinda Nandi,David Waterson,Radha Shandil,Meenakshi Balganesh,Vasan K. Sambandamurthy,Anand Kumar V. Raichurkar,Abhijeet Deshpande,Anirban Ghosh,Disha Awasthy,Gajanan Shanbhag,Gulebahar Sheikh,Helen H.J. McMiken,Jayashree Puttur,Jitendar Reddy,Jim Werngren,Jon Read,Mahesh Kumar,Manjunatha R,Murugan Chinnapattu,Prashanti Madhavapeddi,Praveena Manjrekar,Reetobrata Basu,Sheshagiri Gaonkar,Sreevalli Sharma,Sven Hoffner,Vaishali Humnabadkar,Venkita Subbulakshmi,Vijender Panduga +30 more
TL;DR: Novel inhibitors in the pyrrolamide class which kill Mycobacterium tuberculosis through inhibition of ATPase activity catalyzed by the GyrB domain of DNA gyrase are identified and could be developed as novel anti-TB agents.
Journal ArticleDOI
Antituberculosis drugs: reducing efflux=increasing activity.
TL;DR: An experimental approach for studying efflux of compounds selected under the More Medicines for Tuberculosis research project is presented, and a few examples of how, for tuberculosis drug discovery, efflux matters are shown.
Journal ArticleDOI
Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase
Vikas Patil,Kale Manoj Ganpat,Anandkumar Raichurkar,B. Bhaskar,Dwarakanath Prahlad,Meenakshi Balganesh,Santosh Nandan,P. Shahul Hameed +7 more
TL;DR: This Letter describes the synthesis and SAR studies of this class of molecules by variation of two parts of the molecule, the phenyl and triazolopyrimidine rings, and describes optimisation of enzyme potency, whole cell potency and evidence of mechanism of action.
Journal ArticleDOI
Evaluation of Killing Kinetics of Anti-Tuberculosis Drugs on Mycobacterium tuberculosis Using a Bacteriophage-Based Assay
TL;DR: The concentration- dependent killing of streptomycin, the time-dependent killing of ethambutol and the profiling of an experimental anti-mycobacterial compound are shown for the first time by these 2 methods.